Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Olson

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Blood Advances|January 24, 2024
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantationCurtis Marcoux, Rima M Saliba, Whitney Wallis, et al.
Leukemia & Lymphoma|October 17, 2015
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphomaPhilip A Thompson, Travis Perera, David Marin, et al.
Frontiers in Immunology|May 17, 2021
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 PatientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Transplantation and Cellular Therapy|March 30, 2021
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host DiseaseRohtesh S Mehta, Rima M Saliba, Anna Jan, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinaseSheela A Thomas, Tongmei Li, Keith W Woods, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical TrialUday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Leukemia|July 27, 2021
Decrease post-transplant relapse using donor-derived expanded NK-cellsStefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Blood Advances|January 24, 2024
Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantationCurtis Marcoux, Rima M Saliba, Whitney Wallis, et al.
Leukemia & Lymphoma|October 17, 2015
Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphomaPhilip A Thompson, Travis Perera, David Marin, et al.
Frontiers in Immunology|May 17, 2021
High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 PatientsUri Greenbaum, Kimberly Klein, Fernando Martinez, et al.
Transplantation and Cellular Therapy|March 30, 2021
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host DiseaseRohtesh S Mehta, Rima M Saliba, Anna Jan, et al.
Transplantation and Cellular Therapy|May 23, 2021
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaFevzi F Yalniz, Rima M Saliba, Uri Greenbaum, et al.
Blood|July 22, 2016
IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantationAnushruti Sarvaria, Rafet Basar, Rohtesh S Mehta, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinaseSheela A Thomas, Tongmei Li, Keith W Woods, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2020
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical TrialUday Popat, Rohtesh S Mehta, Roland Bassett, et al.
Pageof 8